The Leukaemia Foundation has announced its role as the host and sponsor of the New Directions in Leukaemia Research (NDLR) Conference 2024. The conference will take place from March 4 to March 6, 2024, in Adelaide, South Australia.
Mr Tim Murphy, General Manager of Blood Cancer Partnerships at the Leukaemia Foundation said, NDLR 2024 offers a unique opportunity for scientists and clinicians to come together and discuss the latest advancements in leukaemia research.
“Our goal is to harness the collective expertise of attendees to drive progress towards our vision of zero lives lost to blood cancer by 2035.”
The event is held over three days and will include presentations from renowned blood cancer clinicians and researchers. Attendees will have the opportunity to engage with experts in basic and translational research, as well as explore emerging therapies making an impact in clinical settings.
The Leukaemia Foundation’s National Research Program plays a pivotal role in supporting the work of researchers and clinicians across Australia, furthering the organisation’s mission to eradicate blood cancer.
With an unwavering commitment to funding research innovations driving rapid advancements in treatments, diagnostics, and novel therapies, the Leukaemia Foundation’s National Research Program has invested over $60 million over the past 24 years to propel groundbreaking discoveries and interventions across blood cancer.
